Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Mar 10:14:1517049.
doi: 10.3389/fonc.2024.1517049. eCollection 2024.

Editorial: KRAS in stage IV non-small cell lung cancer

Affiliations
Editorial

Editorial: KRAS in stage IV non-small cell lung cancer

Anneloes L Noordhof et al. Front Oncol. .
No abstract available

Keywords: KRAS G12C; KRAS inhibitors; Kirsten Rat Sarcoma (KRAS); lung adenocarcinoma; non-small cell lung cancer.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.

Comment on

  • Editorial on the Research Topic KRAS in stage IV non-small cell lung cancer

References

    1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. (2021) 71:209–49. doi: 10.3322/caac.21660 - DOI - PubMed
    1. Asmara OD, Tenda ED, Singh G, Pitoyo CW, Rumende CM, Rajabto W, et al. . Lung cancer in Indonesia. J Thorac Oncol. (2023) 18:1134–45. doi: 10.1016/j.jtho.2023.06.010 - DOI - PubMed
    1. Hendriks LEL, Dingemans AC, De Ruysscher DKM, Aarts MJ, Barberio L, Cornelissen R, et al. . Lung cancer in the Netherlands. J Thorac Oncol. (2021) 16:355–65. doi: 10.1016/j.jtho.2020.10.012 - DOI - PubMed
    1. Prior IA, Hood FE, Hartley JL. The frequency of ras mutations in cancer. Cancer Res. (2020) 80:2969–74. doi: 10.1158/0008-5472.CAN-19-3682 - DOI - PMC - PubMed
    1. Moore AR, Rosenberg SC, McCormick F, Malek S. RAS-targeted therapies: is the undruggable drugged? Nat Rev Drug Discovery. (2020) 19:533–52. doi: 10.1038/s41573-020-0068-6 - DOI - PMC - PubMed

Publication types

LinkOut - more resources